US President Donald Trump has announced a phased tariff policy on imported generic drugs, keeping duties at 0% for two years from August 1, 2026, before increasing them to 100% and later 200% to encourage pharmaceutical manufacturing within the United States.
Key Highlights
- 0% tariff on imported generic drugs until August 1, 2028.
- Tariffs will rise to 100% for one year and 200% thereafter.
- Policy aims to reshore pharmaceutical manufacturing to the US.
- Branded and patented medicines remain unchanged under existing policy.
US President Donald Trump has announced a new phased tariff policy on imported generic medicines, giving overseas pharmaceutical manufacturers a two-year period to establish production facilities in the United States before steep import duties come into effect.
Under the policy, generic drug imports will continue to attract zero tariffs from August 1, 2026, for two years. After this period, imports will face a 100% tariff for one year, followed by a 200% tariff, according to Trump’s announcement on social media.
Trump said the move is designed to encourage pharmaceutical companies to shift manufacturing to the United States, strengthening domestic production and reducing reliance on imported medicines. He described the tariff structure as an incentive for companies to invest in American manufacturing facilities.
The announcement, however, did not clarify whether companies that begin constructing manufacturing plants during the transition period would qualify for exemptions or whether production must be operational before higher tariffs take effect. No countries or pharmaceutical companies were specifically mentioned.
Trump also clarified that the new tariff timeline applies only to generic medicines, while the existing policy for patented, branded and innovative drugs will remain unchanged. He added that pharmaceutical manufacturing facilities are already expanding rapidly across the United States.
The phased tariff plan marks a significant shift in US pharmaceutical trade policy, giving global generic drug manufacturers limited time to adapt while advancing the administration’s goal of expanding domestic drug production.
FAQs
1. What is Trump’s new generic drug tariff policy?
Imported generic medicines will remain tariff-free for two years from August 1, 2026, before tariffs rise to 100% and later 200%.
2. Why is the US imposing tariffs on generic drugs?
The policy aims to encourage pharmaceutical companies to establish manufacturing facilities in the United States.
3. Will branded medicines be affected?
No. Trump said the policy for patented and branded medicines will remain unchanged.
4. When will the higher tariffs take effect?
The 100% tariff will begin after the initial two-year tariff-free period, followed by a 200% tariff one year later.
